Is Actavis Inc (ACT) a Buy at This Price?
Actavis Inc (NYSE:ACT), the largest generic drug company in the US, just got even bigger.
Teva Pharmaceutical Industries Ltd (TEVA)
Market is closed
News
- First
- << Previous
- 241 - 250
- Next >>
Amgen, Inc. (AMGN): Is It a Buy Now?
Amgen announced its latest quarterly results after the market close on Tuesday. Investors were clearly disappointed, with shares falling 6% in after-hours trading.
Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Will The Transition Be Effective?
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), a pharmaceuticals company that makes money off of branded drugs as well as generics, is an interesting example of a company in transition.
Gilead Sciences, Inc. (GILD) or Biogen Idec Inc. (BIIB)? This Is What the Perfect Biotech Would Look Like
I don't know about you, but I'm pretty stoked for the NFL draft this Thursday.
Amgen, Inc. (AMGN): Can Earnings Keep It Soaring?
On Tuesday, Amgen, Inc. (NASDAQ:AMGN) will release its latest quarterly results.
Johnson & Johnson (JNJ): Will Dividend Growth for This Dividend King Start Slowing?
Johnson & Johnson (NYSE:JNJ) has been considered a dividend growth star for a number of years now.
Another Israel ETF Could Be On The Way
Van Eck's Market Vectors unit, the fifth-largest U.S.
Abbott Laboratories (ABT): This Company & Ache Labs: A Perfect Match?
Abbott Laboratories (NYSE:ABT) has begun its new future swimmingly.
Hedge Funds Are Selling Novo Nordisk A/S (ADR) (NYSE:NVO) - Forest Laboratories, Inc. (NYSE:FRX), Dr. Reddy's Laboratories Limited (ADR) (NYSE:RDY)
To most stock holders, hedge funds are assumed to be slow, outdated financial tools of the past.
Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Is One of 5 Key Stocks in This Healthcare-Focused Hedgie’s Portfolio
Healthcare stocks aren’t for everyone, but one way average investors can learn more about this space is by paying attention to those who make a career out of it.
- First
- << Previous
- 241 - 250
- Next >>
Billionaire Hedge Funds
